Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Respiratory Health Associated with Systemic Metal Exposure in Post 9/11 Veterans in the Department of Veterans Affairs Toxic Embedded Fragment Registry.
Hines SE, Gaitens JM, Brown CH, Glick DR, Reback M, Chin KH, Lawrence E, Cavanaugh KL, Lawson WE, Sriram P, Beck L, Duch J, Aguayo SM, Permana P, McDiarmid MA. Hines SE, et al. Among authors: lawrence e. J Occup Environ Med. 2024 May 10. doi: 10.1097/JOM.0000000000003143. Online ahead of print. J Occup Environ Med. 2024. PMID: 38739926
Understanding psychosis complexity through a syndemic framework: A systematic review.
Zahid U, Lawrence EG, de Freitas DF, Parri LA, Quadros W, Hua P, Harriss E, Oliver D, Hosang GM, Bhui K. Zahid U, et al. Among authors: lawrence eg. Neurosci Biobehav Rev. 2024 Apr;159:105614. doi: 10.1016/j.neubiorev.2024.105614. Epub 2024 Mar 2. Neurosci Biobehav Rev. 2024. PMID: 38432448 Free article. Review.
Diagnosis and management of subarachnoid haemorrhage.
Thilak S, Brown P, Whitehouse T, Gautam N, Lawrence E, Ahmed Z, Veenith T. Thilak S, et al. Among authors: lawrence e. Nat Commun. 2024 Feb 29;15(1):1850. doi: 10.1038/s41467-024-46015-2. Nat Commun. 2024. PMID: 38424037 Free PMC article. Review.
Phase I/II study to evaluate consolidative hypofractionated radiation therapy for boosting the residual primary disease in combination with durvalumab after definitive chemoradiation therapy for stage III non-small cell lung cancer (NSCLC): study protocol for a prospective trial.
Coutu B, Lawrence E, Ganti AK, Marr A, Wichman C, Zhang C. Coutu B, et al. Among authors: lawrence e. J Thorac Dis. 2024 Jan 30;16(1):750-759. doi: 10.21037/jtd-23-304. Epub 2024 Jan 29. J Thorac Dis. 2024. PMID: 38410608 Free PMC article.
691 results